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Abstract
Distribution of prion infectivity in organs and tissues is important in understanding prion disease pathogenesis and
designing strategies to prevent prion infection in animals and humans. Transmission of prion disease from cattle to humans
resulted in banning human consumption of ruminant nervous system and certain other tissues. In the present study, we
surveyed tissue distribution of prion infectivity in mice with prion disease. We show for the first time detection of infectivity
in white and brown fat. Since high amounts of ruminant fat are consumed by humans and also incorporated into animal
feed, fat-containing tissues may pose a previously unappreciated hazard for spread of prion infection.
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Introduction
Prion diseases, also known as transmissible spongiform enceph-
alopathies (TSE), are infectious progressive fatal neurodegenera-
tive diseases which affect humans as well as wild and domestic
animals [1–3]. Some examples include Creutzfeldt-Jakob disease
(CJD) in humans, scrapie in sheep and goats, bovine spongiform
encephalopathy (BSE) in cattle and chronic wasting disease
(CWD) in North American deer and elk. Usually the infection
shows a strong species-specificity, but cross-species infection can
occur naturally or experimentally often at a low efficiency. The
possibility that humans might contract prion disease by exposure
to infected animals is a major public health concern. In the past
decades transmission of BSE from cattle appears to account for the
occurrence of variant CJD in humans. This has led to the necessity
of identifying the tissues harboring infectivity in diseased animals.
Previously, infectivity has been surveyed in multiple organs of
sheep [4,5], goats [6], cattle [7,8], deer [9], mink [10], mice
[11,12], and hamsters [13]. The highest levels of infectivity and
protease-resistant prion protein (PrPres) were found in nervous
system tissues such as brain, spinal cord and eye. In some animal
species and prion strains, intermediate to low levels of infectivity
and PrPres were found in spleen, lymph node, peripheral nerves
and intestine. The lowest infectivity levels were found in a variety
of organs including skeletal muscle, tongue, salivary gland, heart,
liver, and kidney. It was also noteworthy that in BSE infected
cattle, both spleen and skeletal muscle were negative or extremely
low by infectivity testing, suggesting that BSE infected cattle differ
from other models in this aspect [7,8]. PrPres was also detected by
western blot in tongue of hamsters and sheep [13–15], skeletal
muscles of mice, sheep, and hamsters [12,13,16,17] and cardiac
muscle of deer and elk [18]. IHC analysis for PrPres in these
tissues was also often positive in myocytes and nerves while fat
tissue adjacent to muscle was not noted to be positive [13–21].
In some studies no infectivity was detected in blood and serum
[4,7,11], but more recently low levels of blood infectivity have been
detected using more sensitive methods [22]. Blood is also positive for
PrPres using protein misfolding cyclic amplification (PMCA) [23],
however this test does not directly measure infectivity.
We previously found a high level of infectivity in brain and heart
of scrapie-infected tg44 transgenic mice expressing anchorless PrP
[24], suggesting the possibility that these mice might have an
increased infection at other extraneural sites [25]. In our
preliminary histopathology studies of infected tg44 mice we noted
the presence of PrPres in fat tissues (B. Chesebro, unpublished
observations). Adipose tissue is widely consumed by humans and is
also used in some animal feeds, but has not been specifically
studied as a possible site of accumulation of prion infectivity.
Therefore, in the present study we examined white and brown fat
tissues as well as several other tissues of scrapie-infected WT and
tg44 mice by quantitative end-point dilution infectivity titration as
well as immunoblotting and IHC for presence of PrPres. White
and brown fat tissues of both types of mice were found to contain
significant scrapie infectivity, and thus appear to be a previously
unrecognized site of prion accumulation in vivo.
Results
Infectivity Titers in Tissues of Scrapie-Infected WT and
tg44 Mice
In the present paper we examined the tissue distribution of
prion infectivity in scrapie-infected WT mice. Infectivity was
detected in all tissues tested including some plasmas (Table 1).
Brain titers were 8.3–9.3 log10ID50/gram, titers in skeletal muscle,
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log10ID50/gram, and very low titers were seen in plasma (2.9-
,1.8 log10ID50/ml). To our knowledge this is the first report of
infectivity in brown or white fat tissue of any species.
We reported previously that scrapie-infected tg44 mice did not
develop clinical signs over a 700 day period [24]. In the present
study after scrapie infection of tg44 mice, high titers were found in
brain, skeletal muscle, tongue, white fat and brown fat (Table 1).
Plasma titers were 3.0–5.3 log10ID50/ml in mice infected with 22L
scrapie, and ranged from 2.5 to,1.8 log10ID50/ml in mice
infected with RML scrapie. These low plasma titers indicated that
contamination by plasma could not account for the high level of
infectivity found in other positive tissues described here.
Detection of PrPres by Immunoblot or
Immunohistochemistry
Because prion infectivity and PrPres are usually associated, we
examined the tissues presented in Table 1 for PrPres detectable by
immunoblot with antibody D13 [26]. In tissues of tg44 mice, PrPres
was readily detected by standard immunoblot in brain, heart,
tongue, colon and brown fat (Figure 1A). By loading an increased
amount of tissue extract, PrPres was also detected in white fat,
muscle and one liver (out of 9 tested), but not in testes (Figure 1A).
In infected WT mice, immunoblotting showed a strong PrPres
signal from brain but the other seven tissues tested were negative
(Figure 1B). To enhance the sensitivity of PrPres detection, fat
tissues of WT mice were also tested by PTA immunoblot [27,28].
Results were still negative, however using this method with fat
tissues there were some technical problems which were not
observed on positive control brain samples (data not shown).
Tissues were also examined by immunohistochemistry (IHC) for
presence of PrPres (Figure 2). WT mice had detectable PrPres only
in brain, neuronal ganglia of colon (Figure 2D, lower panel) and
spleen (not shown). Lack of detectable PrPres in WT brown fat,
white fat, muscle, tongue and liver appeared to be related to lower
infectivity titers in these tissues compared to brain (Table 1). In
contrast, in infected tg44 mice, extraneural tissues including
lamina propria of colon, brown fat, white fat, muscle and tongue
had PrPres detectable by IHC (Figure 2). Furthermore, this PrPres
was stained by the amyloid stain, Thioflavin S, in both brown and
white fat (Figure 3A–3D) and in other tissues (not shown). These
IHC results were in agreement with the previous infectivity data
(Table 1) and immunoblotting data (Figure 1A) and confirmed
that there was a high level of extraneural prion disease infection in
multiple tissues of tg44 mice.
Discussion
The present results indicate that white fat and brown fat are
possible tissue sources of prion infectivity which might play a role in
transmission of prion disease. In vivo brown fat has a limited
distribution, usually found in young animals in the intrascapular
region and around various organs such as heart and kidney. In adult
ruminants brown fat is minimal. Therefore, brown fat from infected
animals is unlikely to be consumed by humans in large amounts. In
contrast, humans often consume large amounts of ruminant white
Table 1. Infectivity titers in scrapie-infected WT and anchorless PrP transgenic (tg44) mice.





Brain 9.3, 10.3 9.8 9.0, 9.3, 8.3
e 8.9
Skeletal muscle (quadriceps) 7.5, 9.3, 6.3
c,7 . 7
c 7.7 3.8, 4.5, $5.8, $5.8, 6.3, 5.0
e 5.2
Tongue 9.0, 9.3, 7.8
c 8.7 5.5, 3.8, 3.8, 5.5, 5.0
e 4.7
White fat (subcutaneous) 9.5, 7.8
c 8.6 5.3, 5.3, 4.0, 3.8, 5.5, 4.3
e 4.7
White fat (perirenal) 9.5, 7.5, 7.8
c,7 . 6
c 8.1 ,2.8, 3.3, 3.6, $4.8, 3.5, 5.2
e 3.9
Brown fat $9.8, 9.3, 8.3
e,7 . 6
e 8.7 5.3, 3.8, 3.8 4.3
Liver 5.5, 8.3, 6.1
c,5 . 4
c 6.3 3.8, 3.3, 3.5, 3.3, 4.1, 3.9 3.6
Plasma
d 5.3




e 3.2 2.9, 1.8, 2.1, ,1.8, ,1.8, ,1.8
e 1.8
aFollowing IC inoculation, tissues were analyzed at 482–654 days for tg 44 mice and 155–165 dpi for WT mice. Plasmas were analyzed from 365–596 dpi for tg44 and
155–165 dpi for WT mice.
bTiters are expressed as log10ID50/gram tissue or ml plasma [37]. When recipient mice were inoculated with 50 ml of a 1% tissue homogenate or 50 ml of a 1/100 plasma
dilution, the lower limit of detection was 2.8 log10ID50/gram tissue or ml plasma. Some mice were inoculated with 50 ml of a 1/10 dilution of plasma, so the lower limit
of detection was 1.8 log10ID50/ml plasma. Tissues from mock-inoculated or uninoculated mice had no detectable infectivity.
cTwo tg44 mice inoculated IP were sacrificed at 441 and 692 dpi.
dThese low or negative plasma titers differed from a previous report [25], where titers of .5.0 and .7.0 log10ID50/ml were found in two anchorless PrP tg mice at 480
and 507 days post-infection with the RML scrapie strain.
eMice inoculated with RML scrapie strain.
Mice without footnote were inoculated with 22L scrapie strain.
doi:10.1371/journal.ppat.1000232.t001
Author Summary
Prion diseases, also known as transmissible spongiform
encephalopathies, are infectious progressive fatal neurode-
generative diseases which affect humans as well as wild and
domestic animals. Distribution of prion infectivity in organs
and tissues is important in understanding prion disease
pathogenesis and designing strategies to prevent prion
infection in animals and humans. We show for the first time
the presence of prion infectivity in white fat and brown fat
tissues of mice with prion disease. Our results suggest that
fat tissues of domestic or wild animals infected with prions
may posean unappreciated hazard for spread of infectionto
humans or domestic animals. The presence of prion
infectivity in fat suggests that additional consideration may
be required to eliminate from the food chain any fat from
ruminants suspected of exposure to or infection with prions.
Thus, this finding has implications for public health, food
safety, and prion disease prevention strategies.
Prion Infectivity in Fat
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fat is often intertwined with muscle cells, and it is impossible to
separate the two cell types. However, white fat, free of muscle, is
found in subcutaneous, retroperitoneal, intraperitoneal, perirenal
and other regions. Such fat is used in many processed meat products
such as sausages and canned meats, and is also used in animal feeds.
Our present data show clearly that fat in the absence of muscle has
significant infectivity titers, which are similar to titers in muscle
containing fat (Table 1). Since our skeletal muscle samples are
unavoidably contaminated by white fat, it is possible that fat might
be a contributor to the infectivity found in muscle. In support of this
possibility we found PrPres detectable by IHC at high levels in white
fat associated with skeletal muscle in some tg44 mice (Figure 4). In
contrast, other groups did not mention seeing PrPres in muscle-
associated fat tissue in animals where myocytes themselves were seen
to be positive by IHC [13–20].
It is unclear why there is accumulation of PrPres and infectivity in
adipose tissues. One possibility might be the high level of innervation
by the autonomic nervous system in both brown and white fat. In
WT mice, nerves should express cell membrane anchored PrP
C
(PrPsen). Sympathetic nerves have been previously implicated in
transfer of scrapie infectivity from spleen to brain in mice [29], and
they might also play a role in infection of fat in WT mice. In tg44
mice the mechanism of fat infection is likely to be different as there is
no anchored PrPsen on the nerves. We currently postulate a role for
connective tissue structures in this process.
Infectivity in fat might also contribute to environmental
contamination following the death of prion infected animals.
Although infectivity titers are lower in fat and muscle than in CNS,
the large mass of fat and muscle makes the total infectivity from
these sources similar. Furthermore, fat and muscle are readily
accessible to the environment after death, whereas the CNS is
highly confined in skull and vertebral column. These factors might
increase the importance of fat and muscle as sources of spread of
prion disease among animals.
The low or negative plasma titers found in tg44 and WT mice
indicate that residual plasma cannot account for the high
infectivity levels seen in fat and other tissues (Table 1). However,
low levels of plasma or blood-borne infectivity might still be a
mechanism for spread of infectivity among tissues in tg44 mice and
possibly also WT mice. Similarly transmission of low level blood
Figure 1. Immunoblot detection of PrPres from various tissues
of 22L scrapie-infected anchorless PrP tg44 mice and WT mice.
Blots were developed using D13 anti-PrP [26]. No PrPres was detected
in uninoculated tg44 or WT mice. For tg44 mice (A), lane 1, mock
infected tg44 mouse brain, 1.0 mg tissue equivalents. Lanes 2–6 were
loaded with 0.25–0.5 mg tissue equivalents and developed using an
enhanced chemiluminescence exposure of 5 seconds, and lanes 7–13
were loaded with 1.0 mg tissue equivalents and exposed for 1–
2 minutes. Lane 11, liver was negative, and lane 12 was the only
positive liver of nine tested. In tg44 mice, spinal cord, spleen, lymph
node, intestines, kidney, and lung were also positive, and eye and skin
were negative (data not shown). Note different PrPres banding pattern
seen in tg44 mice: predominant band is the 18 kD unglycosylated form.
Next in abundance is the 22kD monoglycosylated form. The 25kD
diglycosylated form is barely visible in lanes 5, 6, 9, and 10. Dimeric PrP
bands at 36kD are seen most clearly in lanes 3, 5, 6, and 9. For WT mice
(B), lane 1 was loaded with 0.25 mg tissue equivalents while lanes 2–8
were loaded with 1.0 mg tissue equivalents. Blot was exposed for
2 minutes to search for possible weak bands in lanes 2–8. Lane 1 was
overexposed, but showed usual PrPres banding pattern for 22L mouse
scrapie brain. Results are representative of tissues from at least five mice
analyzed in each group.
doi:10.1371/journal.ppat.1000232.g001
Figure 2. Immunohistochemical detection of PrPres in tissues
of 22L infected tg44 and WT mice. Each tissue is presented as a
pair, tg44 on top and WT on the bottom. Tissue sections were stained
with D13 anti-PrP (red). (A,B) Brain. (C,D) Colon. The arrow in (C) shows
extensive PrP deposition in the lamina propria. The red nuclear staining
of the epithelial cells is an artifact. (D) Top, PrP-negative villi and lamina
propria; bottom, PrP-positive enteric ganglion in the muscularis layer.
(E,F) Brown fat. (G,H) White fat. (I,J) Muscle. In (I) the arrow indicates PrP
accumulation on the surface of a myocyte. White fat adjacent to the
muscle also shows PrP staining (arrowhead). (K,L) Tongue. In (K) the
arrows indicate PrPres staining near the subepithelial layer of the
tongue. The arrowhead shows PrPres adjacent to a blood vessel. Scale
bars indicate 25 mm, except in (I,J) where bars are 12 mm.
doi:10.1371/journal.ppat.1000232.g002
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BSE-infected sheep [30], and also accounts for some rare cases of
human variant CJD [31,32].
In this study extraneural infection was much higher in tg44 mice
expressing anchorless PrP than in WT mice. The explanation of this
findingisunclear.PossiblysolubleanchorlessPrPfacilitatesspreadof
infection from CNS to extraneural sites by blood, lymph or nerve-
mediated transport. Alternatively, the long asymptomatic survival
time of tg44 mice might also contribute to high level extraneural
infection. This could also be a factor in many animal prion diseases
wherethetimecourseislong,i.e.2–5yearsormore,andmightallow
higher extraneural infectivity in fat tissues [7,33–35].
The present data using a mouse model shows the proof of
principle that brown and white fat tissues can be important sites of
Figure 3. Amyloid PrPres in brown and white fat from a homozygous tg44 mouse. Tissues shown are from a tg44 mouse inoculated with
22L scrapie and euthanized at 350 days post infection. (A,B) Brown fat. (C,D) White fat. (A,C) Staining with anti-PrP antibody D13 shows a distinct
perilobular and perivascular distribution of PrPres. (B,D) Amyloid staining with Thioflavin S shows a similar distribution pattern of amyloid.. (A,B) and
(C,D) were approximately 12 micrometers from each other, respectively. Scale bar in (A,B) is 200 micrometers and 100 micrometers in (C,D).
doi:10.1371/journal.ppat.1000232.g003
Figure 4. PrP in white fat and adjacent skeletal muscle. Detection of PrPres (red staining) used D13 anti-PrP antibody. (A) Myocytes (MS)
adjacent to white fat (WF) of a homozygous tg44 mouse at 375 days post-infection with 22L scrapie. PrPres staining in fat was much more intense
than in muscle (arrows), suggesting a lower level of infection in muscle. Nerves (N) had minimal staining. White fat showed smaller than usual lipid
lobules, probably a consequence of clinical wasting. (B) Uninfected tg44 mouse. Fat, muscle, nerve, and brown fat (BF) are negative for PrPres. Scale
bars indicate 200 micrometers.
doi:10.1371/journal.ppat.1000232.g004
Prion Infectivity in Fat
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in the future to prion infected large animals such as cattle, sheep
and cervids where there may be greater potential for contamina-
tion of human or domestic animal food chains. We are currently
doing this experiment with fat from CWD deer; however, it will
require an additional year to gather this data, and this result is
therefore beyond the scope of the present paper. Such studies may
be difficult because of the lower titers seen in these large animals
compared to rodent scrapie models. For example, we often detect
titers of 9–10 logID50/gram of mouse brain, whereas in brain
from BSE cattle [8], and scrapie sheep [4] titers reported are 7–8
logID50/gram. We are finding similar low titers in CWD cervid
brain in our deer PrP transgenic mice (unpublished data). These
results could indicate either that the amount of prion agent present
in ruminant brain is lower than in mice and hamsters or that the
cattle, sheep and deer PrP transgenic mice used for infectivity
assays are less sensitive than the WT mice or hamster PrP
transgenic mice used for rodent scrapie. In either case this might
affect ability to detect infectivity in fat of these important large
animal models.
Materials and Methods
Experimental Mice and Tissues
All mice were housed at the Rocky Mountain Laboratories
(RML) in an AAALAC-accredited facility and experimentation
followed NIH RML Animal Care and Use Committee approved
protocols. Transgenic GPI anchorless PrP mice (tg44) expressed
the transgene in heterozygous form (+/2) and did not express WT
mouse PrP (MoPrnp2/2) [24]. Mice were bred and genotyped at
RML. Weanling C57BL/10 mice were obtained from Jackson
Laboratories, Maine. Four to six week old mice were inoculated
with a 1% brain homogenate of 22L or RML scrapie containing
0.7–1.0610
6 ID50/50 ml. One ID50 is the dose causing infection in
50% of WT mice. One hundred ml was used for IP inoculations
and 50 ml was used for IC inoculations. Animals were observed
daily for onset and progression of scrapie. Tissues were collected
from WT mice when they were in an advanced stage of scrapie
(150–160 dpi). Tg44 mice did not have obvious clinical signs of
disease. Tissues were collected from IC inoculated mice at 482–
654 dpi and from IP inoculated mice at 441 and 692dpi. Skeletal
muscle was obtained from the quadriceps muscle because one
previous report indicated that the lower extremity muscles were
preferable for detection of muscle positive for PrPres or infectivity
[12]. Brown fat associated with kidney and heart were the original
sites where we detected PrPres by IHC. However, to obtain brown
fat free of other structures, we took brown fat overlying the back
muscles between the scapulae. White fat free of muscle was
obtained from both perirenal and subcutaneous regions. Two
additional tg44 plasma pools were collected at 365 and 450 dpi.
Each pool had an equal volume of plasma from three tg44 mice.
For solid tissues a portion of each was flash frozen for future use in
biochemical analysis and bioassays. A second aliquot was
immersed in 10% neutral buffered formalin for immunohisto-
chemisty studies. All individual tissues were collected using new,
sterile instruments to prevent cross contamination between tissues.
Twenty percent (w/v) tissue homogenates were prepared in
0.01 M Tris buffer pH 7.4 using a disposable mortar and pestle
(Kontes, Vineland, NJ), tissue homogenizer (OMNI International
TH, Marietta, GA) or mini-beadbeater (Biospec products,
Bartlesville, OK). All homogenates were sonicated for 60 sec
using a Vibracell cup-horn sonicator (Sonics, Newtown, NJ),
vortexed and then frozen.
Animal Bioassay
End-point tissue titrations were carried out using homogenates
of infected tissues from WT and tg44 mice. All titrations were done
in C57BL/10 recipient mice from Jackson Laboratories. Addi-
tionally, some samples were also titered in tga20 mice [36], which
have a higher PrP expression level and faster scrapie incubation
periods. Although incubation periods were shorter in tga20 mice
compared to C57BL/10 mice, end-point titers were similar (60.5
log10ID50), and values from both end-points were averaged.
Tissue inocula were made in PBBS+2% FBS by preparing serial
ten-fold dilutions of a 1% (=10
22 dilution) tissue homogenate out
to 10
28 or 10
210. Plasma samples were prepared beginning with
either a 1% or 10% dilution and tested out to 10
25. Fifty mlo f
each dilution was inoculated intracerebrally into 6–12 mice. Mice
were observed daily for onset of scrapie and euthanized when signs
such as ataxia, somnolence, kyphosis, and weakness with rear leg
clasping reflex were present. Scrapie infection was confirmed by
western blot analysis of brain homogenates. Mice that did not
become clinically sick were monitored a minimum of 600 days.
Healthy mice at this point were considered uninfected for purposes
of determining the tissue titer. Titers were calculated using the
Spearman/Karber formula [37]. The final value reported was
adjusted to show the log10ID50/gram or ml of tissue.
Immunoblotting
Tissue sets from infected WT and tg44 mice and brains from
bioassay recipients were analyzed for the presence of PrPres by
immunoblot. PrPres preparation was done as previously described
[38]. Briefly, 20 ml of a 20% tissue homogenate was adjusted to
100 mM Tris HCl (pH 8.3), 1% Triton X-100, and 1% sodium
deoxycholate in a total volume of 31 ml. Samples were treated with
50 mg/ml of proteinase K for 45 minutes at 37uC. The reaction was
stopped by adding 2 ml of 0.1 M phenylmethylsulfonyl fluoride and
placed on ice for 5 min. An equal volume of 26Laemmli sample
buffer(Biorad, Hercules, CA) wasadded, and then tubes were boiled
5 minutes. Samples were frozen at 220 until electrophoresed on a
16% SDS-PAGE gel (Invitrogen, CA). Immunoblots were probed
with D13 anti-PrP antibody (InPro Biotechnology, Inc., S. San
Francisco, CA) followed by a peroxidase-conjugated anti-human
IgG secondary antibody (Sigma, St. Louis, MO). Bands were
detected using enhanced chemiluminescence substrate (ECL) as
directed (Amersham, now GE Healthcare).
Immunohistochemistry
Tissues were removed and placed in 3.7% phosphate-buffered
formalin for 3 to 5 days before dehydration and embedding in
paraffin. Serial 4 mm sections were cut using a standard Leica
microtome, placed on positively charged glass slides and dried
overnight at 56u C. For PrPres detection slides were rehydrated in
0.1M citrate buffer, pH 6.0 and then heated at 120u C, 22psi for
20m in a decloaking chamber (Biocare, Walnut Creek, CA).
Immunohistochemical staining was performed using the Ventana
automated Nexus stainer (Ventana, Tucson, AZ). Staining for PrP
used a standard avidin-biotin complex immunoperoxidase proto-
col using anti-PrP antibody D13 at a dilution of 1:500–1:1500 (In-
Pro Biotechnology), biotinylated anti-human IgG at 1:500
(Jackson Laboratories), and avidin-horseradish peroxidase fol-
lowed by amino-ethyl carbazole (Ventana). Amyloid staining was
done using a five minute immersion in 1.0% w/v of Thioflavin S
(MP Biomedicals). Slides were rinsed in 80% EtOH (3x) and water
(1x) prior to mounting and coverslipping. The staining of PrPres
and amyloid was observed using an Olympus BX51 microscope
and Microsuite FIVE software.
Prion Infectivity in Fat
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